Blog
biote Q2 Earnings Call Highlights
Key Points
- Interested in biote Corp.? Here are five stocks we like better.
- Second-quarter performance weakened: Revenue fell 9.5% year over year to $44.2 million, while Biote posted a $7.4
Blue Bird Q3 Earnings Call Highlights
Key Points
- Interested in Blue Bird Corporation? Here are five stocks we like better.
- Strong Q3 performance: Blue Bird reported $517 million in revenue and record adjusted EBITDA of $71
Biodesix Q2 Earnings Call Highlights
Key Points
- Interested in Biodesix, Inc.? Here are five stocks we like better.
- Revenue increased 34% year over year to $26.9 million, driven by a 42% rise in diagnostic testing revenue and a
Billiontoone Q2 Earnings Call Highlights
Key Points
- Interested in Billiontoone, Inc.? Here are five stocks we like better.
- Billiontoone’s Q2 revenue surged 64% year over year to $109.4 million, driven by a 35% increase in test volume
Axon Enterprise Q2 Earnings Call Highlights
Key Points
- Interested in Axon Enterprise, Inc? Here are five stocks we like better.
- Axon reported strong Q2 growth: Revenue rose 35% year over year to $904 million, prompting the company to
Amplitude Q2 Earnings Call Highlights
Key Points
- Interested in Amplitude, Inc.? Here are five stocks we like better.
- Strong Q2 growth: Revenue rose 21% year over year to $100.9 million, while ARR increased 22% to $410 million
AppLovin Q2 Earnings Call Highlights
Key Points
- Interested in AppLovin Corporation? Here are five stocks we like better.
- Second-quarter results fell below guidance: Revenue rose 53% year over year to $1.92 billion and adjusted
Barrett Business Services Q2 Earnings Call Highlights
Key Points
- Interested in Barrett Business Services, Inc.? Here are five stocks we like better.
- Q2 growth was modest: Gross billings rose 2.6% year over year to $2.29 billion, while diluted EPS
Arcutis Biotherapeutics Q2 Earnings Call Highlights
Key Points
- Interested in Arcutis Biotherapeutics, Inc.? Here are five stocks we like better.
- Strong financial performance: Arcutis reported Q2 2026 net product revenue of $129.9 million, up 59%
Amtech Systems Q3 Earnings Call Highlights
Key Points
- Interested in Amtech Systems, Inc.? Here are five stocks we like better.
- Strong AI-driven growth: Fiscal Q3 revenue rose 14% year over year to $22.4 million, while Thermal Processing
Alto Ingredients Q2 Earnings Call Highlights
Key Points
- Interested in Alto Ingredients, Inc.? Here are five stocks we like better.
- Alto Ingredients reported its fourth consecutive quarter of profitability, with second-quarter net sales
ADMA Biologics Q2 Earnings Call Highlights
Key Points
- Interested in ADMA Biologics Inc? Here are five stocks we like better.
- Second-quarter revenue rose 2% to $124.4 million, driven by a 24% increase in ASCENIV sales to $102.9 million
Airgain Q2 Earnings Call Highlights
Key Points
- Interested in Airgain, Inc.? Here are five stocks we like better.
- Second-quarter revenue rose to $13.7 million, up 19% sequentially, while adjusted EBITDA turned positive at
Akebia Therapeutics Q2 Earnings Call Highlights
Key Points
- Interested in Akebia Therapeutics, Inc.? Here are five stocks we like better.
- Vafseo revenue rose sharply to $21.3 million in Q2 2026, up 34% sequentially and 60% year over year
American Coastal Insurance Q2 Earnings Call Highlights
Key Points
- Interested in American Coastal Insurance Corporation? Here are five stocks we like better.
- Second-quarter net income was $21.9 million, while gross written premiums fell 5.3% year
AbCellera Biologics Q2 Earnings Call Highlights
Key Points
- Interested in AbCellera Biologics Inc.? Here are five stocks we like better.
- ABCL635 data is expected very soon: AbCellera completed enrollment and initial dosing ahead of schedule in
Banco Santander Chile Q2 Earnings Call Highlights
Key Points
- Interested in Banco Santander Chile? Here are five stocks we like better.
- Strong profitability: Second-quarter net income rose 40% year over year and sequentially to more than CLP
BlueLinx Q2 Earnings Call Highlights
Key Points
- Interested in BlueLinx Holdings Inc.? Here are five stocks we like better.
- BlueLinx delivered stronger second-quarter results, with sales up more than 4% year over year to $814
Chemours Q2 Earnings Call Highlights
Key Points
- Interested in The Chemours Company? Here are five stocks we like better.
- Second-quarter performance exceeded profit expectations despite sales falling slightly short, as pricing
BrightView Q3 Earnings Call Highlights
Key Points
- Interested in BrightView Holdings, Inc.? Here are five stocks we like better.
- Revenue grew 1.3% year over year to $718 million in Q3 2026, driven by a 2.3% increase in land
Archrock Q2 Earnings Call Highlights
Key Points
- Interested in Archrock, Inc.? Here are five stocks we like better.
- Strong core performance: Archrock reported $67 million in net income, $213 million in adjusted EBITDA and $0.38 in
Brink's Q2 Earnings Call Highlights
Key Points
- Interested in Brink's Company (The)? Here are five stocks we like better.
- Brink’s delivered strong Q2 results, with 4% organic revenue growth, 11% adjusted EBITDA growth to $257
Ardent Health Q2 Earnings Call Highlights
Key Points
- Interested in Ardent Health, Inc.? Here are five stocks we like better.
- Q2 performance was mixed: Ardent Health reported $1.62 billion in revenue and $115 million in adjusted
Brookfield Asset Management Q2 Earnings Call Highlights
Key Points
- Interested in Brookfield Asset Management Ltd.? Here are five stocks we like better.
- Strong second-quarter results: Brookfield Asset Management reported fee-related earnings of $808
Angel Studios Q2 Earnings Call Highlights
Key Points
- Interested in Angel Studios, Inc.? Here are five stocks we like better.
- Revenue and membership surged: Second-quarter revenue rose 28% year over year to $111 million, driven by a